Fluoretiq Limited of Bristol at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Service

Fluoretiq Limited

Unit DX, Albert Road St. Philips Central, B52 0XJ Bristol
United Kingdom of Great Britain and Northern Ireland

This company is co-exhibitor of
MEDICA Start-up Park - Messe Düsseldorf GmbH

Hall map

MEDICA 2019 hall map (Hall 13): stand E56-06

Fairground map

MEDICA 2019 fairground map: Hall 13

Contact

James Preece

Phone
+447720694965

Email
j.preece@fluoretiq.com

Neciah Dorh

Phone
01174034077

Email
n.dorh@fluoretiq.com

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.04  Microbiology testing
  • 03.04.03  Rapid tests in microbiology

Rapid tests in microbiology

Our products

Product category: Rapid tests in microbiology

NANOPLEX™ technology

We have developed award-winning NANOPLEX™ technology for rapid identification and enumeration of bacterial pathogens. 

NANOPLEX™ can support clinicians to achieve same-day-decision consultations; reducing turn-around-times from 48 hours to 15 minutes with simple and easy to use bacterial testing. GPS is 200x faster than conventional diagnostics and quantitatively detects bacteria in a 6-log dynamic range.

Bacteria are identified by proprietary nano-material labels which are then identified using an advanced optical measurement system, in a simple 3 step process.

More Less

Product category: Rapid tests in microbiology

FluoretiQ’s QPS

FluoretiQ’s QPS toolkit is an optical measurement platform with the flexibility to perform fluorescence or absorption measurements with simultaneous photon counting and spectroscopy. Get in touch to discuss how our QPS toolkit can support your research.

More Less

Company news

Date

Topic

Download

Oct 17, 2019

MEDICA Startup Park- Introductory video

More Less

About us

Company details

 “Around 700,000 people around the world die annually due to drug-resistant infections. If no action is taken, it has been estimated that drug-resistant infections will kill 10 million people a year by 2050”

-Dame Sally Davies, UK Chief Medical Officer (AMR review)

 FluoretiQ was founded to respond to the steadily growing threat of antibiotic resistance with an intuitive diagnostic that redefines pathology testing 200x faster in simple 3-step process.

Based at the UnitDX biosciences hub in the heart of Bristol, FluoretiQ are thriving in a recognised European City of Innovation.

More Less

Company data

Number of employees

1-19

Area of business

Diagnostics